ANN Pharmacy

Dapasmart tablets contain Dapagliflozin (5 mg), a sodium-glucose co-transporter 2 (SGLT2) inhibitor designed to lower blood glucose levels by promoting the excretion of excess sugar through urine. It is prescribed for type 2 diabetes mellitus, and also offers benefits in managing heart failure and chronic kidney disease.

Myformin 1 gm Tablets contain Metformin Hydrochloride, a trusted and widely prescribed oral anti-diabetic medication used for the management of Type 2 Diabetes Mellitus. It belongs to the class of biguanides, working primarily by reducing glucose production in the liver and improving the body's response to insulin.

Mounjaro 15 mg is a Tirzepatide injection supplied in a pre-filled pen, used for the management of type 2 diabetes mellitus and is also being explored for weight management under medical supervision. Tirzepatide is a dual GIP and GLP-1 receptor agonist, which helps regulate blood sugar levels and supports weight loss by improving insulin sensitivity, slowing gastric emptying, and reducing appetite.

Mounjaro 12.5 mg is a once-weekly Tirzepatide injection, delivered via a pre-filled, single-use subcutaneous pen. Tirzepatide is a cutting-edge dual GIP and GLP-1 receptor agonist designed for adults with type 2 diabetes mellitus to improve blood sugar control, alongside diet and exercise. It is also being researched and prescribed off-label for weight management in obesity, under medical supervision.

Mounjaro 10 mg is a once-weekly Tirzepatide injection, delivered via a pre-filled, single-use subcutaneous pen. Tirzepatide is a cutting-edge dual GIP and GLP-1 receptor agonist designed for adults with type 2 diabetes mellitus to improve blood sugar control, alongside diet and exercise. It is also being researched and prescribed off-label for weight management in obesity, under medical supervision.

Mounjaro 7.5 mg is a once-weekly Tirzepatide injection, delivered via a pre-filled, single-use subcutaneous pen. Tirzepatide is a cutting-edge dual GIP and GLP-1 receptor agonist designed for adults with type 2 diabetes mellitus to improve blood sugar control, alongside diet and exercise. It is also being researched and prescribed off-label for weight management in obesity, under medical supervision.

Trucility 1.5 mg Injection contains Dulaglutide, a long-acting GLP-1 receptor agonist used to manage Type 2 Diabetes Mellitus in adults. It helps lower blood sugar levels by enhancing insulin secretion, slowing gastric emptying, and reducing appetite. Trucility is administered once weekly via subcutaneous injection, making it a convenient and effective choice for long-term diabetes management.

Triptican 10 mg Tablets contain Amitriptyline Hydrochloride, a tricyclic antidepressant used to treat symptoms of depression, anxiety, and certain types of nerve pain (neuropathic pain). It helps improve mood, sleep quality, and overall sense of well-being by restoring the balance of neurotransmitters in the brain. Manufactured under strict quality standards, Triptican ensures consistent effectiveness and patient safety.